tiprankstipranks
Trending News
More News >
Fresenius Medical Care AG & Co. KGaA (GB:0H9X)
LSE:0H9X

Fresenius Medical Care AG & Co. KGaA (0H9X) Stock Statistics & Valuation Metrics

Compare
3 Followers

Total Valuation

Fresenius Medical Care AG & Co. KGaA has a market cap or net worth of €11.46B. The enterprise value is €23.54B.
Market Cap€11.46B
Enterprise Value€23.54B

Share Statistics

Fresenius Medical Care AG & Co. KGaA has 293,413,450 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding293,413,450
Owned by Insiders
Owned by Institutions<0.01%

Financial Efficiency

Fresenius Medical Care AG & Co. KGaA’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.37%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)5.37%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee175.20K
Profits Per Employee8.73K
Employee Count112,035
Asset Turnover0.63
Inventory Turnover6.82

Valuation Ratios

The current PE Ratio of Fresenius Medical Care AG & Co. KGaA is 11.7. Fresenius Medical Care AG & Co. KGaA’s PEG ratio is 0.15.
PE Ratio11.7
PS Ratio0.60
PB Ratio0.89
Price to Fair Value0.89
Price to FCF6.72
Price to Operating Cash Flow4.21
PEG Ratio0.15

Income Statement

In the last 12 months, Fresenius Medical Care AG & Co. KGaA had revenue of 19.63B and earned 978.00M in profits. Earnings per share was 3.36.
Revenue19.63B
Gross Profit5.03B
Operating Income1.84B
Pretax Income1.51B
Net Income978.00M
EBITDA3.34B
Earnings Per Share (EPS)3.36

Cash Flow

In the last 12 months, operating cash flow was 2.68B and capital expenditures -915.37M, giving a free cash flow of 1.77B billion.
Operating Cash Flow2.68B
Free Cash Flow1.77B
Free Cash Flow per Share6.02

Dividends & Yields

Fresenius Medical Care AG & Co. KGaA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.62
52-Week Price Change-13.25%
50-Day Moving Average39.36
200-Day Moving Average43.48
Relative Strength Index (RSI)47.60
Average Volume (3m)129.88K

Important Dates

Fresenius Medical Care AG & Co. KGaA upcoming earnings date is May 5, 2026, TBA (Confirmed).
Last Earnings DateFeb 24, 2026
Next Earnings DateMay 5, 2026
Ex-Dividend Date

Financial Position

Fresenius Medical Care AG & Co. KGaA as a current ratio of 1.26, with Debt / Equity ratio of 102.95%
Current Ratio1.26
Quick Ratio0.92
Debt to Market Cap0.91
Net Debt to EBITDA3.63
Interest Coverage Ratio4.77

Taxes

In the past 12 months, Fresenius Medical Care AG & Co. KGaA has paid 321.00M in taxes.
Income Tax321.00M
Effective Tax Rate0.21

Enterprise Valuation

Fresenius Medical Care AG & Co. KGaA EV to EBITDA ratio is 7.18, with an EV/FCF ratio of 13.58.
EV to Sales1.22
EV to EBITDA7.18
EV to Free Cash Flow13.58
EV to Operating Cash Flow8.94

Balance Sheet

Fresenius Medical Care AG & Co. KGaA has €1.73B in cash and marketable securities with €13.70B in debt, giving a net cash position of -€11.98B billion.
Cash & Marketable Securities€1.73B
Total Debt€13.70B
Net Cash-€11.98B
Net Cash Per Share-€40.81
Tangible Book Value Per Share-€1.86

Margins

Gross margin is 25.62%, with operating margin of 9.36%, and net profit margin of 4.98%.
Gross Margin25.62%
Operating Margin9.36%
Pretax Margin7.70%
Net Profit Margin4.98%
EBITDA Margin17.01%
EBIT Margin9.36%

Analyst Forecast

The average price target for Fresenius Medical Care AG & Co. KGaA is €41.53, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target€41.53
Price Target Upside1.35% Upside
Analyst ConsensusHold
Analyst Count12
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score2
AI Score